Andere Kunden interessierten sich auch für
![Psychopharmaka als Mittel zur Freiheitsbeschränkung]( "Psychopharmaka als Mittel zur Freiheitsbeschränkung")
Psychopharmaka als Mittel zur Freiheitsbeschränkung14,99 €![Pflegewissen Psychopharmaka]( "Pflegewissen Psychopharmaka")
Pflegewissen Psychopharmaka34,99 €![Drugs, Driving and Traffic Safety]( "Drugs, Driving and Traffic Safety")
Drugs, Driving and Traffic Safety213,99 €![Beyond Assessment of Quality of Life in Schizophrenia]( "Beyond Assessment of Quality of Life in Schizophrenia")
Beyond Assessment of Quality of Life in Schizophrenia37,99 €![Novel Antischizophrenia Treatments]( "Novel Antischizophrenia Treatments")
Novel Antischizophrenia Treatments293,99 €![Antidepressiva absetzen]( "Antidepressiva absetzen")
Antidepressiva absetzen35,00 €![Neue Psychiatrie]( "Neue Psychiatrie")
Neue Psychiatrie25,00 €
The field of nicotine psychopharmacology has rapidly expanded in recent years, driven by theoretical, pharmaceutical and tobacco-related interests. It was challenging to represent the many promising areas of research, from molecular to clinical to epidemiological, within a single volume.
This book provides relatively focused reviews written by leading researchers on their areas of recent interest. Each article was reviewed by experts, producing a reference that will be useful to researchers, students, health professionals, and to the growing number of people involved in efforts to regulate tobacco product contents and designs nationally and internationally.
The fact that tobacco ingestion can affect how people feel and think has been known for millennia, placing the plant among those used spiritually, honori?cally, and habitually (Corti 1931; Wilbert 1987). However, the conclusion that nicotine - counted for many of these psychopharmacological effects did not emerge until the nineteenth century (Langley 1905). This was elegantly described by Lewin in 1931 as follows: "The decisive factor in the effects of tobacco, desired or undesired, is nicotine. . . "(Lewin 1998). The use of nicotine as a pharmacological probe to und- stand physiological functioning at the dawn of the twentieth century was a landmark in the birth of modern neuropharmacology (Limbird 2004; Halliwell 2007), and led the pioneering researcher John Langley to conclude that there must exist some "- ceptive substance" to explain the diverse actions of various substances, including nicotine, when applied to muscle tissue (Langley 1905). Research on tobacco and nicotine progressed throughout the twentieth century, but much of this was from a general pharmacological and toxicological rather than a psychopharmacological perspective (Larson et al. 1961). There was some attention to the effects related to addiction, such as euphoria (Johnston 1941), tolerance (Lewin 1931), and withdrawal (Finnegan et al. 1945), but outside of research supported by the tobacco industry, addiction and psychopharmacology were not major foci for research (Slade et al. 1995; Hurt and Robertson 1998; Henning?eld et al. 2006; Henning?eld and Hartel 1999; Larson et al. 1961).
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
This book provides relatively focused reviews written by leading researchers on their areas of recent interest. Each article was reviewed by experts, producing a reference that will be useful to researchers, students, health professionals, and to the growing number of people involved in efforts to regulate tobacco product contents and designs nationally and internationally.
The fact that tobacco ingestion can affect how people feel and think has been known for millennia, placing the plant among those used spiritually, honori?cally, and habitually (Corti 1931; Wilbert 1987). However, the conclusion that nicotine - counted for many of these psychopharmacological effects did not emerge until the nineteenth century (Langley 1905). This was elegantly described by Lewin in 1931 as follows: "The decisive factor in the effects of tobacco, desired or undesired, is nicotine. . . "(Lewin 1998). The use of nicotine as a pharmacological probe to und- stand physiological functioning at the dawn of the twentieth century was a landmark in the birth of modern neuropharmacology (Limbird 2004; Halliwell 2007), and led the pioneering researcher John Langley to conclude that there must exist some "- ceptive substance" to explain the diverse actions of various substances, including nicotine, when applied to muscle tissue (Langley 1905). Research on tobacco and nicotine progressed throughout the twentieth century, but much of this was from a general pharmacological and toxicological rather than a psychopharmacological perspective (Larson et al. 1961). There was some attention to the effects related to addiction, such as euphoria (Johnston 1941), tolerance (Lewin 1931), and withdrawal (Finnegan et al. 1945), but outside of research supported by the tobacco industry, addiction and psychopharmacology were not major foci for research (Slade et al. 1995; Hurt and Robertson 1998; Henning?eld et al. 2006; Henning?eld and Hartel 1999; Larson et al. 1961).
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.